4.7 Review

Leishmaniasis: drugs in the clinic, resistance and new developments

期刊

DRUG RESISTANCE UPDATES
卷 7, 期 4-5, 页码 257-266

出版社

CHURCHILL LIVINGSTONE
DOI: 10.1016/j.drup.2004.07.002

关键词

Leishmania; leishmaniasis; kala azar; pentavalent antimonials; stibogluconate; Pentostam; meglumine antimoniate; Glucantime; pentamidine; amphotericin B; miltefosine; fluconazole; ABC transporters

向作者/读者索取更多资源

The control of Leishmania infections relies primarily on chemotherapy. The arsenal of drugs available for treating Leishmania infections is limited and includes pentavalent antimonials, pentamidine, amphotericin B, miltefosine, fluconazole and few other drugs at various stages of their development process. In this review, we will discuss the latest results regarding resistance mechanisms to drugs used in the clinic against Leishmania infections. (C) 2004 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据